Melittin has been shown to have anti-neoplastic effects on lung cancer cells by lowering the protein expression of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor 1 (HIF-1) (Zhang and Chen, 2017). Here, VEGFA is linked to lung carcinoma.